NAMSA Executive and Leadership Team

October, 2026

Leadership Overview

NAMSA has 7 executives leading key functions including operations, financial management, revenue growth, human resources, medical oversight, and laboratory services.

Focused on accelerating medical device development, NAMSA delivers integrated laboratory, clinical research, and regulatory consulting services to improve global patient health outcomes through rigorous scientific excellence.

Leadership Roles at NAMSA

  • Chief Financial Officer - Scott Sellick
  • Chief Operating Officer - Elizabeth Kempen
  • Global Division President, Laboratory Services - Gina Skolmowski
  • Lead Business Development Executive & Chief Revenue Officer - Andrew Suri
  • Chief Human Resources Officer - Roseanne Sawyer
  • Senior Global Business Development Executive & Chief Revenue Officer - Alexa Liantonio
  • Chief Medical Officer, At Namsa - Adam Saltman
  • Scott Sellick - Chief Financial Officer

    Scott Sellick, the Chief Financial Officer at NAMSA, manages the fiscal health and long-term financial strategy of the organization. Sellick oversees capital allocation, budgeting, and financial reporting to support the expansion of laboratory and clinical research capabilities. The Chief Financial Officer evaluates investment opportunities in new technologies and service lines to maintain a competitive edge in the medical device market. Scott Sellick directs financial planning and analysis to ensure the company meets its revenue targets while maintaining operational efficiency. By providing data-driven insights to the board, the Chief Financial Officer facilitates informed decision-making regarding global market expansion and resource distribution. This role requires rigorous oversight of financial controls and risk management protocols. Through disciplined fiscal management, Sellick secures the financial stability necessary for the company to continue providing high-value consulting services to medical device manufacturers worldwide.

    Elizabeth Kempen - Chief Operating Officer

    Elizabeth Kempen, the Chief Operating Officer at NAMSA, directs all internal operational workflows to ensure seamless integration across laboratory and clinical research divisions. Kempen optimizes resource allocation to accelerate medical device product development cycles for global clients. By refining internal processes, the Chief Operating Officer maintains high standards of regulatory compliance and service delivery efficiency. Elizabeth Kempen monitors cross-departmental performance metrics to identify bottlenecks and implement scalable solutions. This leadership role involves close collaboration with the executive team to align operational capacity with market demand. Through the implementation of advanced project management frameworks, Kempen drives organizational productivity and supports the overarching mission of delivering high-quality research services. The Chief Operating Officer ensures that all operational activities remain consistent with the strategic goals of the organization, ultimately fostering long-term growth and operational excellence within the competitive medical research landscape.

    Gina Skolmowski - Global Division President, Laboratory Services

    Gina Skolmowski, the Global Division President, Laboratory Services at NAMSA, directs the operations and strategic growth of the company's extensive laboratory testing facilities. Skolmowski oversees the implementation of advanced testing methodologies and ensures compliance with international quality standards for medical device evaluation. The Global Division President, Laboratory Services manages the technical infrastructure and personnel required to deliver high-precision laboratory results for global clients. Gina Skolmowski drives continuous improvement initiatives to enhance testing throughput and accuracy. By aligning laboratory capabilities with the evolving needs of the medical device industry, the Global Division President, Laboratory Services supports the company's mission to accelerate product development. This role involves coordinating with clinical and regulatory teams to provide comprehensive, integrated service solutions. Through effective leadership of the laboratory division, Skolmowski ensures that the company maintains its reputation for scientific excellence and reliable data generation in the global marketplace.

    Andrew Suri - Lead Business Development Executive & Chief Revenue Officer

    Andrew Suri, the Lead Business Development Executive & Chief Revenue Officer at NAMSA, architects the commercial strategy to drive revenue growth across the medical device consulting sector. Suri identifies emerging market opportunities and cultivates strategic partnerships with global manufacturers. The Lead Business Development Executive & Chief Revenue Officer aligns sales initiatives with the company's laboratory and clinical research service offerings to maximize market penetration. Andrew Suri leads the commercial team in executing complex contract negotiations and client acquisition strategies. By analyzing market trends, the Lead Business Development Executive & Chief Revenue Officer ensures that service delivery remains relevant to evolving regulatory and reimbursement landscapes. This leadership role involves coordinating with technical teams to tailor solutions for diverse client needs. Through proactive business development, Suri expands the company's footprint in key international markets, ensuring consistent revenue streams and sustained commercial success.

    Roseanne Sawyer - Chief Human Resources Officer

    Roseanne Sawyer, the Chief Human Resources Officer at NAMSA, directs the talent acquisition and organizational development strategies essential for maintaining a high-performing workforce. Sawyer oversees recruitment, employee engagement, and professional development programs tailored to the specialized needs of medical research professionals. The Chief Human Resources Officer fosters a culture of innovation and scientific excellence by implementing robust training and retention initiatives. Roseanne Sawyer manages workforce planning to ensure the company possesses the necessary expertise to support complex clinical and regulatory projects. By aligning human capital strategies with business objectives, the Chief Human Resources Officer drives organizational agility and employee satisfaction. This role involves collaborating with leadership to cultivate a diverse and inclusive environment that attracts top-tier talent. Through strategic talent management, Sawyer ensures the organization remains equipped to meet the rigorous demands of the medical device industry while supporting long-term growth.

    Alexa Liantonio - Senior Global Business Development Executive & Chief Revenue Officer

    Alexa Liantonio, the Senior Global Business Development Executive & Chief Revenue Officer at NAMSA, spearheads international expansion efforts to capture market share in the global medical device consulting space. Liantonio develops and executes high-level sales strategies focused on large-scale clinical research and regulatory service contracts. The Senior Global Business Development Executive & Chief Revenue Officer analyzes regional market dynamics to tailor service offerings for diverse international regulatory environments. Alexa Liantonio coordinates with cross-functional teams to ensure that global client requirements are met with precision and speed. By fostering long-term relationships with key industry stakeholders, the Senior Global Business Development Executive & Chief Revenue Officer drives sustainable revenue growth across multiple continents. This leadership role involves identifying strategic growth vectors and optimizing the sales pipeline to support the company's global mission. Through targeted business development, Liantonio strengthens the company's position as a premier partner for medical device innovation.
    Alexa Liantonio

    Adam Saltman - Chief Medical Officer, At Namsa

    Adam Saltman, the Chief Medical Officer, At Namsa at NAMSA, provides clinical leadership and scientific oversight for all medical device research and development projects. Saltman ensures that clinical trials and regulatory submissions adhere to the highest medical standards and safety protocols. The Chief Medical Officer, At Namsa evaluates the clinical efficacy of new medical technologies and provides expert guidance to clients navigating complex regulatory pathways. Adam Saltman collaborates with laboratory and research teams to interpret clinical data and support evidence-based decision-making. By maintaining deep expertise in medical science, the Chief Medical Officer, At Namsa ensures that the company's consulting services remain at the forefront of clinical innovation. This role involves engaging with regulatory bodies and industry experts to advocate for patient safety and product quality. Through rigorous medical oversight, Saltman supports the company's commitment to accelerating the development of life-saving medical devices.
    Adam Saltman

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding NAMSA Top Executives and Leadership Team

    Who leads NAMSA?
    NAMSA is led by Scott Sellick (Chief Financial Officer), along with executives such as Elizabeth Kempen (Chief Operating Officer) and Gina Skolmowski (Global Division President, Laboratory Services).
    Who is part of NAMSA’s executive team?
    The executive team of NAMSA includes leaders such as Scott Sellick (Chief Financial Officer), Elizabeth Kempen (Chief Operating Officer), Gina Skolmowski (Global Division President, Laboratory Services) and other senior executives.
    How many executives does NAMSA have?
    NAMSA has 7 executives leading key business areas.
    What roles are included in NAMSA’s leadership team?
    The leadership team of NAMSA includes roles such as Chief Financial Officer, Chief Operating Officer, Global Division President, Laboratory Services, Lead Business Development Executive & Chief Revenue Officer, Chief Human Resources Officer.